LifeSci Venture Partners

Investor type

VC

Founded

2017

AUM

-

Location

New York, New York, United States

Investment Ticket

$10-50 m

Investment Stage

Series A Late Stage (Series C+)

Region of investment

North America
Investor profile last updated: 31 August, 2026

Profile

LifeSci Venture Partners is a healthcare investor based in New York, established in 2017. The firm was founded by a team of professionals with backgrounds in science, medicine, and investment, and it focuses on collaborative capital to accelerate medical breakthroughs. Their unique approach combines clinical, scientific, and investment expertise, allowing them to support innovative companies in the healthcare sector.

The firm invests in clinical-stage opportunities, specifically targeting companies that have achieved proof-of-concept and have a clear path to public markets within 12 to 18 months. LifeSci Venture Partners collaborates with dynamic entrepreneurs, clinicians, and scientists, providing founder-aligned terms and patient, flexible capital. They leverage a vast network of over 200 experienced professionals across various sectors of healthcare to enhance business development for their portfolio companies.

Notable investments include PDB 7T9I - thyroid stimulating hormone receptor, and several other companies that are reshaping medical care through novel approaches. LifeSci Venture Partners is committed to long-term support and rigorous diligence, ensuring they back transformative business models in the healthcare industry.

Industry

Pharmaceuticals Medical Devices Healthcare Services Digital Biotechnology Software MedTech HealthTech

Contacts

Name
Title
Email
avatar
Ryan Cinalli, Ph.D. Partner & CSO
Partner & CSO
r•••@•••
avatar
Ira Kalfus, M.D. Venture Partner
Venture Partner
i•••@•••
Upgrade to see contacts
avatar
uOjcpWk1bmxhTBM4 uOjcpWk1bmxhTBM4
uOjcpWk1bmxhTBM4
avatar
uOjcpWk1bmxhTBM4 uOjcpWk1bmxhTBM4
uOjcpWk1bmxhTBM4
avatar
uOjcpWk1bmxhTBM4 uOjcpWk1bmxhTBM4
uOjcpWk1bmxhTBM4
Investment-team contacts for LifeSci Venture Partners — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about LifeSci Venture Partners

LifeSci Venture Partners is a venture capital firm. It backs companies at Series A and Late Stage (Series C+), writing tickets of $10-50 m.
LifeSci Venture Partners is located in New York, New York, United States.
LifeSci Venture Partners was founded in 2017.
LifeSci Venture Partners invests in companies and startups in Pharmaceuticals, Medical Devices, Healthcare Services, Digital, Biotechnology, Software, MedTech, HealthTech.
LifeSci Venture Partners invests in companies and startups in North America.
LifeSci Venture Partners invests in companies and startups at Series A, Late Stage (Series C+).
LifeSci Venture Partners usually invests $10-50 m on average.
LifeSci Venture Partners can be reached through its website lifesciventure.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for LifeSci Venture Partners — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query LifeSci Venture Partners directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 31 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.